Fagos antibacterianos, péptidos de fagos y métodos de uso de los mismos

Un bacteriofago purificado que tiene un genoma que comprende al menos el 99% de identidad de secuencia con la secuencia de nucleotidos de la SEQ ID NO: 3, y que tiene actividad antibacteriana contra una o mas cepas de Pseudomonas aeruginosa. The present invention is directed to the field of phage th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Rodrigues Pardal Dias Antunes Marçal da Silva, Filipa Maria, da Costa Garcia, Miguel Ângelo, Grancho Lourenço, Sara Ferreira Llorente, Rodrigues Leandro, Clara Isabel, Sousa de São José, Carlos Jorge
Format:	Patent
Sprache:	spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Un bacteriofago purificado que tiene un genoma que comprende al menos el 99% de identidad de secuencia con la secuencia de nucleotidos de la SEQ ID NO: 3, y que tiene actividad antibacteriana contra una o mas cepas de Pseudomonas aeruginosa. The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophage F770/05 comprising the nucleic acid sequence of SEQ ID NO:3, isolated tail tape measure protein or tail protein thereof, compositions comprising the novel bacteriophage and/or isolated proteins and methods for the treatment and prevention of bacterial infection, either alone or in combination with other antibacterial therapies, e.g., antibiotics or other phage therapies.